Boc-L-MeThr(Bzl)-OH

Boc-L-MeThr(Bzl)-OH is a protected L-amino acid building block bearing a tert-butoxycarbonyl (Boc) group on the amino functionality, a side-chain methyl substituent characteristic of MeThr, and a benzyl (Bzl) protecting group on the side-chain hydroxyl. This protection pattern is commonly leveraged to control chemoselectivity during peptide assembly, enabling downstream coupling while minimizing side-chain participation. As a Boc-protected amino acid, it is typically used in workflows where Boc chemistry is preferred for stepwise peptide construction and segment coupling.

1. Boc-Based Peptide Synthesis

Boc-L-MeThr(Bzl)-OH is used as a protected residue for incorporating MeThr with a benzyl-protected side-chain hydroxyl into peptides assembled under Boc-based strategies. Peptide synthesis groups rely on the Boc group to maintain the amino functionality in a protected, coupling-ready state while the Bzl protection suppresses undesired side reactions from the hydroxyl during coupling and deprotection cycles. This makes the building block particularly relevant for preparing peptides where the MeThr side-chain oxygen must remain inert until the intended late-stage deprotection step.

2. Protected Residue Segment Building

Boc-L-MeThr(Bzl)-OH supports the preparation of peptide segments for solution-phase or convergent assembly, where orthogonal control of functional groups is essential. In custom peptide manufacturing and medicinal chemistry research, protected amino acid residues like this are selected to improve reproducibility across multi-step condensations, allowing the MeThr side-chain to be carried through coupling steps without competing reactivity. The Boc/Bzl protection combination also fits established protection-deprotection logic used to generate defined peptide intermediates prior to final global deprotection and purification.

3. Medicinal Chemistry Peptidomimetic Development

Boc-L-MeThr(Bzl)-OH is frequently incorporated into peptide-like scaffolds and peptidomimetic analogs used in structure-activity relationship studies, where controlled presentation of a side-chain hydroxyl is important for maintaining targeted conformations and interaction patterns. Medicinal chemistry teams use this protected residue to build analog libraries with consistent stereochemical and functional-group placement, while the benzyl-protected hydroxyl helps avoid premature side reactions during synthesis. The resulting protected peptide intermediates can be carried forward for subsequent functionalization or final deprotection to reveal the native hydroxyl for downstream evaluation workflows.

1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

2. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

5. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L